beta
CYTR
CytRx Corporation
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
CytRx Corp is a biopharmaceutical research and development company in the United States. Its key drug candidate is the aldoxorubicin, which is developed to address serious diseases such as soft tissue sarcoma (STS).
Market Cap: 57.5 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.cytrx.com
Shares Outstanding: 27.6 Million
Float: 26.3 Million
Dividend: 0.0 (0.0%)
Beta: 4.212781
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 2201 trading days
From: 2014-01-10 To: 2019-06-07
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|